-
1 Comment
Fusen Pharmaceutical Company Limited is currently in a long term downtrend where the price is trading 31.3% below its 200 day moving average.
From a valuation standpoint, the stock is 93.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.2.
Fusen Pharmaceutical Company Limited's total revenue rose by 13.5% to $239M since the same quarter in the previous year.
Its net income has increased by 18.2% to $35M since the same quarter in the previous year.
Finally, its free cash flow grew by 130.0% to $53M since the same quarter in the previous year.
Based on the above factors, Fusen Pharmaceutical Company Limited gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| CurrencyCode | HKD |
| Exchange | HK |
| ISIN | KYG370981030 |
| PE Ratio | None |
|---|---|
| Market Cap | 214M |
| Target Price | None |
| Beta | 0.16 |
| Dividend Yield | None |
Fusen Pharmaceutical Company Limited, an investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; heat-clearing and detoxicating oral solutions; nicardipine hydrochloride injections; and other products. It also offers cardio cerebrovascular, blood pressure and sugar reduction, tonifying, qi-regulating, anti-anemia, antibacterial and anti-inflammatory, gastrointestinal tract, and expectorant cough category products. It also researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold, fever, cardiovascular diseases, and anemia. In addition, the company offers business management and consulting services; and engages in the sale of construction material and electricity. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1652.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
